Loss News Briefs

Microdosing GLP-1s Like Wegovy, Zepbound May Still Lead to Weight Loss. Research shows that microdosing GLP-1 medications may still lead to weight loss. Tatsiana Volkava · Moment/Getty Recent research suggests that people may still lose weight while staying on the lowest starting doses of GLP-1 medications, such as Wegovy or Zepbound, for longer periods. After one year, people taking sustained low dose tirzepatide lost about 5.5% of their body weight, while those taking sustained low dose semaglutide lost about 2.2%. Lower doses were associated with more modest weight loss than higher doses, but sustained low dose semaglutide was also associated.

8-Hour Time-Restricted Eating Window May Lead to Greater Weight Loss. Research shows that an 8-hour eating window may lead to greater weight loss than other time-restricted eating patterns. FreshSplash · E+/Getty An 8-hour eating window was linked to greater weight loss than a 12-hour window or no time restriction, but not significantly more than a 10-hour window. Time-restricted eating (TRE) is a form of intermittent fasting that limits eating to a set number of hours each day without necessarily restricting calories. Shorter eating windows were linked to modest weight loss, but researchers found limited effects on blood pressure, blood sugar,.

Red Sox's Gray 'frustrated' by lack of trust from manager in loss to Yankees. Red Sox ace Sonny Gray said after Wednesday's loss to the Yankees that he was frustrated for being lifted after throwing only 70 pitches.

Swiss glaciers suffer 'disastrous' year of ice loss, threatening water supplies. Scientists say such rapid melting is no longer surprising given the pace of climate change.